Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 168

1.

Prognostic Value of PD-1 and PD-L1 Expression in Patients with High-Grade Upper Tract Urothelial Carcinoma.

Krabbe LM, Heitzplatz B, Preuss S, Hutchinson RC, Woldu SL, Singla N, Boegemann M, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Rapoport LM, Glybochko PV, Roscigno M, Bolenz C, Bensalah K, Sagalowsky AI, Shariat SF, Lotan Y, Xylinas E, Margulis V.

J Urol. 2017 Jun 28. pii: S0022-5347(17)77052-8. doi: 10.1016/j.juro.2017.06.086. [Epub ahead of print]

PMID:
28668287
2.

Telephone - delivered quality of life after 365 male stress urinary incontinence (SUI) operations.

Bretterbauer KM, Huber ER, Remzi M, Huebner W.

Int Braz J Urol. 2016 Sep-Oct;42(5):986-992. doi: 10.1590/S1677-5538.IBJU.2015.0194.

3.

Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract.

Wirth GJ, Haitel A, Moschini M, Soria F, Klatte T, Hassler MR, Bensalah K, Briganti A, Karam JA, Lotan Y, Margulis V, Raman JD, Remzi M, Rioux-Leclercq N, Robinson BD, Rouprêt M, Wood CG, Shariat SF.

World J Urol. 2017 Jun;35(6):943-949. doi: 10.1007/s00345-016-1946-8. Epub 2016 Oct 11.

PMID:
27730305
4.

Postoperative Nomogram for Relapse-Free Survival in Patients with High Grade Upper Tract Urothelial Carcinoma.

Krabbe LM, Eminaga O, Shariat SF, Hutchinson RC, Lotan Y, Sagalowsky AI, Raman JD, Wood CG, Weizer AZ, Roscigno M, Montorsi F, Bolenz C, Novara G, Kikuchi E, Fajkovic H, Rapoport LM, Glybochko PV, Zigeuner R, Remzi M, Bensalah K, Kassouf W, Margulis V.

J Urol. 2017 Mar;197(3 Pt 1):580-589. doi: 10.1016/j.juro.2016.09.078. Epub 2016 Sep 23.

PMID:
27670916
5.

HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC).

Soria F, Moschini M, Haitel A, Wirth GJ, Karam JA, Wood CG, Rouprêt M, Margulis V, Karakiewicz PI, Briganti A, Raman JD, Kammerer-Jacquet SF, Mathieu R, Bensalah K, Lotan Y, Özsoy M, Remzi M, Gust KM, Shariat SF.

World J Urol. 2017 Feb;35(2):251-259. doi: 10.1007/s00345-016-1871-x. Epub 2016 Jun 7.

PMID:
27272502
6.

Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma.

Mandalapu RS, Remzi M, de Reijke TM, Margulis V, Palou J, Kapoor A, Yossepowitch O, Coleman J, Traxer O, Anderson JK, Catto J, de la Rosette J, O'Brien T, Zlotta A, Matin SF.

World J Urol. 2017 Mar;35(3):355-365. doi: 10.1007/s00345-016-1859-6. Epub 2016 May 27.

PMID:
27233780
7.

Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary Tract.

Raman JD, Warrick JI, Caruso C, Yang Z, Shuman L, Bruggeman RD, Shariat S, Karam JA, Wood C, Weizer AZ, Remzi M, Haitel A, Bensalah K, Rioux-Leclerq N, Bolenz C, Roscigno M, Krabbe LM, Kapur P, Lotan Y, Margulis V, DeGraff DJ.

Urology. 2016 Aug;94:314.e1-7. doi: 10.1016/j.urology.2016.05.030. Epub 2016 May 20.

8.

Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study.

Favaretto RL, Bahadori A, Mathieu R, Haitel A, Grubmüller B, Margulis V, Karam JA, Rouprêt M, Seitz C, Karakiewicz PI, Cunha IW, Zequi SC, Wood CG, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Jacquet-Kammerer S, Bensalah K, Lotan Y, Bachmann A, Rink M, Briganti A, Shariat SF.

World J Urol. 2017 Jan;35(1):113-120. doi: 10.1007/s00345-016-1835-1. Epub 2016 Apr 29.

9.

Anxiety and depression analyses of patients undergoing diagnostic cystoscopy.

Seklehner S, Engelhardt PF, Remzi M, Fajkovic H, Saratlija-Novakovic Z, Skopek M, Resch I, Duvnjak M, Hruby S, Wehrberger C, Librenjak D, Hübner W, Breinl E, Riedl C.

Qual Life Res. 2016 Sep;25(9):2307-14. doi: 10.1007/s11136-016-1264-z. Epub 2016 Mar 17.

PMID:
26984467
10.

Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.

Fajkovic H, Shariat SF, Klatte T, Vartolomei MD, Lucca I, Mbeutcha A, Rouprêt M, Briganti A, Karakiewicz PI, Margulis V, Rink M, Remzi M, Seitz C, Bensalah K, Mathieu R.

World J Urol. 2016 Oct;34(10):1411-9. doi: 10.1007/s00345-016-1767-9. Epub 2016 Feb 15.

PMID:
26879416
11.

Austrian recommendations on Targeted Hormone Therapy for metastatic, castration-resistant prostate cancer.

Ponholzer A, Loidl W, Bektic J, Dorfinger K, Hruby S, Jeschke K, Kramer G, Krause S, Ludvik G, Remzi M, Roider M, Stoiber F.

Wien Klin Wochenschr. 2016 Feb;128(3-4):156-63. doi: 10.1007/s00508-015-0945-x. Epub 2016 Feb 1.

PMID:
26831188
12.

Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent.

Mbeutcha A, Lucca I, Margulis V, Karam JA, Wood CG, de Martino M, Mathieu R, Haitel A, Xylinas E, Kluth L, Rouprêt M, Karakiewicz PI, Briganti A, Rink M, Rieken M, Weizer AZ, Raman JD, Rioux-Leclecq N, Bolenz C, Bensalah K, Lotan Y, Seitz C, Remzi M, Shariat SF, Klatte T.

World J Urol. 2016 Aug;34(8):1155-61. doi: 10.1007/s00345-015-1737-7. Epub 2015 Dec 11.

PMID:
26658888
13.

Oncologic Outcomes of Kidney Sparing Surgery versus Radical Nephroureterectomy for the Elective Treatment of Clinically Organ Confined Upper Tract Urothelial Carcinoma of the Distal Ureter.

Seisen T, Nison L, Remzi M, Klatte T, Mathieu R, Lucca I, Bozzini G, Capitanio U, Novara G, Cussenot O, Compérat E, Renard-Penna R, Peyronnet B, Merseburger AS, Fritsche HM, Hora M, Shariat SF, Colin P, Rouprêt M.

J Urol. 2016 May;195(5):1354-61. doi: 10.1016/j.juro.2015.11.036. Epub 2015 Nov 21.

PMID:
26612196
14.

Résultats oncologiques du traitement des TVES≤pT2 de l'uretère pelvien par néphro-urétérectomie, résection segmentaire et chirurgie endoscopique : résultats d'une étude multicentrique européenne.

Nison L, Colin P, Remzi M, Shariat S, Klatte T, Yakoubi R, Bozzini G, Capitanio U, Babjuk M, Merseburger A, Cha E, Fritsche H, Novara G, Montorsi F, Hora M, Roupret M.

Prog Urol. 2015 Nov;25(13):807. doi: 10.1016/j.purol.2015.08.182. French. No abstract available.

PMID:
26544377
15.

Prospective, multi-institutional pain assessment of 150 women undergoing diagnostic cystoscopy.

Seklehner S, Saratlija-Novakovic Z, Skopek M, Fajkovic H, Remzi M, Duvnjak M, Resch I, Hruby S, lmHÜBNER W, Librenjak D, Breinl E, Riedl C, Engelhardt PF.

Minerva Urol Nefrol. 2016 Oct;68(5):417-23. Epub 2015 Sep 1.

PMID:
26329755
16.

Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study.

Mathieu R, Klatte T, Margulis V, Karam JA, Rouprêt M, Seitz C, Karakiewicz PI, Fajkovic H, Wood CG, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Bensalah K, Lotan Y, Rink M, Kluth LA, Scherr DS, Robinson BD, Shariat SF.

Urol Oncol. 2015 Nov;33(11):495.e15-22. doi: 10.1016/j.urolonc.2015.06.016. Epub 2015 Jul 27.

PMID:
26228160
17.

TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma.

Youssef RF, Krabbe LM, Shariat SF, Lotan Y, Sagalowsky AI, Raman J, Wood CG, Weizer A, Roscigno M, Montorsi F, Bolenz C, Remzi M, Bensalah K, Kassouf W, Margulis V.

World J Urol. 2015 Dec;33(12):1965-72. doi: 10.1007/s00345-015-1566-8. Epub 2015 May 10.

PMID:
25957592
18.

Prospective multi-institutional study analyzing pain perception of flexible and rigid cystoscopy in men.

Seklehner S, Remzi M, Fajkovic H, Saratlija-Novakovic Z, Skopek M, Resch I, Duvnjak M, Hruby S, Librenjak D, Hübner W, Breinl E, Riedl C, Engelhardt PF.

Urology. 2015 Apr;85(4):737-41. doi: 10.1016/j.urology.2015.01.007.

PMID:
25817101
19.

Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract.

Krabbe LM, Bagrodia A, Haddad AQ, Kapur P, Khalil D, Hynan LS, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Roscigno M, Bolenz C, Bensalah K, Sagalowsky AI, Shariat SF, Lotan Y, Margulis V.

J Urol. 2015 May;193(5):1486-93. doi: 10.1016/j.juro.2014.11.007. Epub 2014 Nov 11.

PMID:
25451830
20.

Evaluation of the prognostic significance of altered mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinoma.

Bagrodia A, Krabbe LM, Gayed BA, Kapur P, Bernstein I, Xie XJ, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Rioux-Leclerq N, Haitel A, Roscigno M, Bolenz C, Bensalah K, Sagalowsky AI, Shariat SF, Lotan Y, Margulis V.

Urology. 2014 Nov;84(5):1134-40. doi: 10.1016/j.urology.2014.07.050. Epub 2014 Oct 24.

PMID:
25443916

Supplemental Content

Loading ...
Support Center